Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production J Herrera-Rodriguez, A Signorazzi, M Holtrop, J de Vries-Idema, ... Vaccine 37 (12), 1630-1637, 2019 | 70 | 2019 |
Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus MP Etna, A Signorazzi, D Ricci, M Severa, F Rizzo, E Giacomini, ... PLoS Pathogens 17 (4), e1009505, 2021 | 11 | 2021 |
In vitro assessment of tick-borne encephalitis vaccine: Suitable human cell platforms and potential biomarkers A Signorazzi, MP Etna, EM Coccia, A Huckriede ALTEX: Alternatives to Animal Experimentation 38 (3), 431-441, 2021 | 7 | 2021 |
In vitro characterization of the innate immune pathways engaged by live and inactivated tick-borne encephalitis virus A Signorazzi, JLA Pennings, MP Etna, M Noya, EM Coccia, A Huckriede Vaccines 9 (6), 664, 2021 | 3 | 2021 |
In vitro approaches for the evaluation of human vaccines A Signorazzi University of Groningen, 2021 | | 2021 |